Drug Design for G-Protein-Coupled Receptors by a Ligand-Based NMR Method

被引:28
|
作者
Bartoschek, Stefan [1 ]
Klabunde, Thomas [1 ]
Defossa, Elisabeth [1 ]
Dietrich, Viktoria [1 ]
Stengelin, Siegfried [1 ]
Griesinger, Christian [2 ]
Carlomagno, Teresa [3 ]
Focken, Ingo [1 ]
Wendt, K. Ulrich [1 ]
机构
[1] Sanofi Aventis Deutschland GmbH, R&D Dept Chem & Analyt Sci Struct Biol TD Metab B, D-65926 Frankfurt, Germany
[2] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37033 Gottingen, Germany
[3] EMBL, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany
关键词
drug design; G-protein-coupled receptors; NMR spectroscopy; structure-activity relationships; TRANSFER DIFFERENCE NMR; INTEGRIN ALPHA(IIB)BETA(3); BINDING; SPECTROSCOPY; CELLS; GPR40;
D O I
10.1002/anie.200905102
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
(Figure Presented) A nonradioactive binding assay relying on NMR methods has been devised for a G-protein-coupled receptor; in addition the INPHARMA methods give access to the relative orientation of multiple ligands and supports ligand-based drug design (see picture of superimposed ligands). The method is fast and does not require any structural information from protein crystal structures. © 2010 Wiley-VCH Verlag GmbH &. Co. KGaA.
引用
收藏
页码:1426 / 1429
页数:4
相关论文
共 50 条